Summit Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.29M Buy
87,272
+15,121
+21% +$881K 0.07% 294
2025
Q4
$3.89M Buy
72,151
+7,498
+12% +$361K 0.06% 313
2025
Q3
$2.92M Sell
64,653
-13,046
-17% -$609K 0.04% 381
2025
Q2
$3.6M Buy
77,699
+58,818
+312% +$2.89M 0.08% 205
2025
Q1
$1.15M Buy
18,881
+4,648
+33% +$271K 0.03% 348
2024
Q4
$805K Sell
14,233
-1,916
-12% -$107K 0.03% 358
2024
Q3
$836K Buy
16,149
+2,800
+21% +$131K 0.03% 293
2024
Q2
$554K Buy
13,349
+5,034
+61% +$225K 0.03% 311
2024
Q1
$451K Buy
8,315
+688
+9% +$35K 0.03% 273
2023
Q4
$391K Sell
7,627
-3,229
-30% -$169K 0.03% 274
2023
Q3
$630K Sell
10,856
-341
-3% -$20.9K 0.05% 211
2023
Q2
$716K Buy
11,197
+546
+5% +$36.6K 0.05% 184
2023
Q1
$738K Buy
10,651
+23
+0.2% +$1.62K 0.06% 142
2022
Q4
$765K Sell
10,628
-2,974
-22% -$224K 0.07% 137
2022
Q3
$967K Buy
13,602
+8,510
+167% +$617K 0.09% 109
2022
Q2
$395K Sell
5,092
-2,364
-32% -$180K 0.04% 169
2022
Q1
$549K Buy
7,456
+3,010
+68% +$202K 0.04% 167
2021
Q4
$277K Buy
4,446
+822
+23% +$48.2K 0.02% 219
2021
Q3
$216K Buy
+3,624
New +$239K 0.02% 211

Other funds holding BMY

Summit Financial's BMY Position: Q1 2026 in Review

Summit Financial increased its Bristol-Myers Squibb (BMY) stake by 21% in Q1 2026, buying an estimated $881K and bringing the position to 87,272 shares worth $5.29M. The position accounts for 0.07% of the portfolio, ranked #294.

Summit Financial first reported a position in BMY in Q3 2021 and has held it in 19 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Summit Financial held 87,272 shares of Bristol-Myers Squibb worth $5.29M as of Q1 2026.
  • Summit Financial bought 15,121 Bristol-Myers Squibb shares in Q1 2026, an estimated $881K.
  • Bristol-Myers Squibb made up 0.07% of Summit Financial's portfolio in Q1 2026, its #294 holding.
  • Summit Financial first reported a position in Bristol-Myers Squibb in Q3 2021 and has held it in 19 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Summit Financial's 13F filing for Q1 2026, filed 15 May 2026.